Author pages are created from data sourced from our academic publisher partnerships and public sources.
Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.
- H. Mariz, E. Sato, S. H. Barbosa, S. H. Rodrigues, A. Dellavance, L. E. C. Andrade
- Arthritis and rheumatism
OBJECTIVE To identify features of antinuclear antibody (ANA)-HEp-2 test results that discriminate ANA-positive healthy individuals and patients with autoimmune rheumatic diseases (ARDs). METHODS We… Expand
Vitamin D deficiency in patients with active systemic lupus erythematosus
- V. C. Borba, J. Vieira, T. Kasamatsu, S. C. Radominski, E. Sato, M. Lazaretti-Castro
- Osteoporosis International
- 1 March 2009
SummaryWe investigated the effects of disease activity on bone metabolism in 36 patients with systemic lupus erythematosus (SLE). Changes in bone remodeling were not explained by corticosteroid use.… Expand
Brachial endothelial function is impaired in patients with systemic lupus erythematosus.
- D. S. N. Lima, E. Sato, V. Lima, F. Miranda, F. H. Hatta
- The Journal of rheumatology
- 1 February 2002
OBJECTIVE To verify if endothelial function is impaired in pre-menopausal women with systemic lupus erythematosus (SLE) and whether endothelial dysfunction is related to disease duration, cumulative… Expand
Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017
Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus.
- M. D. Carvalho, E. Sato, A. S. Tebexreni, Raquel T C Heidecher, S. Schenkman, T. B. Neto
- Arthritis and rheumatism
- 15 December 2005
OBJECTIVE To determine if supervised cardiovascular training improves exercise tolerance, aerobic capacity, depression, functional capacity, and quality of life in patients with systemic lupus… Expand
Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
OBJECTIVE To evaluate the capacity of methotrexate (MTX) to control mild activity of systemic lupus erythematosus (SLE), and to evaluate the capacity of MTX to reduce steroid requirement, as well as… Expand
Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients
This study aimed to evaluate the association between nailfold capillary abnormalities and the presence of Raynaud's phenomenon (RP), anti-U1-RNP, and anti-cardiolipin (aCL) antibodies in SLE… Expand
Consenso brasileiro para o tratamento do lúpus eritematoso sistêmico (LES)
Objetivo: Elaborar recomendacao baseada na melhor evidencia cientifica para o tratamento das diversas manifestacoes do lupus eritematoso sistemico. Metodos: Oito reumatologistas que trabalham em… Expand
Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide.
Twenty three patients with SLE and cutaneous lesions not responsive to chloroquine, photoprotectors and corticosteroid in doses < 0.5 mg/kg/day were treated with thalidomide 300 mg/day. Three… Expand
Antiplatelet therapy for the prevention of arterial ischemic events in takayasu arteritis.
- A. W. S. de Souza, N. Machado, +4 authors E. Sato
- Circulation journal : official journal of the…
- 8 May 2010
BACKGROUND Vessel wall inflammation, atherosclerosis and hypercoagulability may be responsible for ischemic events in Takayasu arteritis (TA). No study has evaluated the effect of antiplatelet… Expand